Epidemiology of Candidemia in Swiss Tertiary Care Hospitals: Secular Trends, 1991–2000
Open accessAbstract
Candida species are among the most common bloodstream pathogens in the United States, where the emergence of azole-resistant Candida glabrata and Candida krusei are major concerns. Recent comprehensive longitudinal data from Europe are lacking. We conducted a nationwide survey of candidemia during 1991-2000 in 17 university and university-affiliated hospitals representing 79% of all tertiary care hospital beds in Switzerland. The number of transplantations and bloodstream infections increased significantly (P<.001). A total of 1137 episodes of candidemia were observed: Candida species ranked seventh among etiologic agents (2.9% of all bloodstream isolates). The incidence of candidemia was stable over a 10-year period. C. albicans remained the predominant Candida species recovered (66%), followed by C. glabrata (15%). Candida tropicalis emerged (9%), the incidence of Candida parapsilosis decreased (1%), and recovery of C. krusei remained rare (2%). Fluconazole consumption increased significantly (P<.001). Despite increasing high-risk activities, the incidence of candidemia remained unchanged, and no shift to resistant species occurred.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 34 cited sources checked · 0 supported · 0 flagged
- Findingown data§ RESULTS · p. 4
A total of 1137 episodes of candidemia were observed in the survey.
“These 6 centers reported 774 (68%) of all 1137 episodes of candidemia recorded in the survey over 10 years.”
Quote in the paperSubstantial claim - Findingown data§ RESULTS · p. 3
Solid-organ transplantations increased 95% from 108 to 211 during 1991-2000 in 3 university hospitals.
“solid-organ transplantations increased 95% during the same period, from 108 to 211 ( ; )”
Quote in the paperNot a substantial claim - Findingown data§ RESULTS · p. 3
Hematopoietic stem cell transplantations increased 124% from 55 in 1992 to 123 in 2000 in 3 university hospitals.
“hematopoietic stem cell transplantations increased 124%, from 55 in 1992 to 123 in 2000 ( ; r p 0.83 P ! .005)”
Quote in the paperNot a substantial claim - Findingown data§ RESULTS · p. 5
The overall distribution of Candida species was stable during 1991-2000.
“Overall, the species distribution was stable (figure 3).”
Quote in the paperNot a substantial claim - Findingown data§ RESULTS · p. 5
During 1991-2000, the incidence of candidemia showed no significant trend in university hospitals and university-affiliated hospitals.
“No significant trend was observed during the 10-year period among university hospitals and universityaffiliated hospitals (figure 1 C ).”
- Also stated in: § DISCUSSION · p. 7 · plain
“In Switzerland, the incidence of candidemia remained essentially unchanged during the 10-year study period.”
Quote in the paperSubstantial claim - Also stated in: § DISCUSSION · p. 7 · plain
- Findingown data§ RESULTS · p. 5
In university-affiliated hospitals, the annual incidence of candidemia rose significantly from 0.23 to 0.56 episodes per 10,000 patient-days during 1991-1996.
“the annual incidence of candidemia in university-affiliated hospitals increased significantly, from 0.23 to 0.56 episodes per 10,000 patient-days”
Quote in the paperNot a substantial claim - Findingown data§ Epidemiology of Candidemia in Swiss T ertiary Care Hospitals: Secular T rends, 1991-2000 · p. 1
C. krusei remained rare, accounting for 2%.
“recovery of C. krusei remained rare (2%)”
Quote in the paperNot a substantial claim- Rests on an assumption: The species identification methods remained consistent across hospitals and over the 10-year period.
- Findingown data§ RESULTS · p. 5
No trend in species-specific incidence was observed when university and university-affiliated hospitals were analyzed separately.
“Similarly, no trend was observed when university and university-affiliated hospitals were analyzed separately.”
Quote in the paperNot a substantial claim - Findingown data§ Epidemiology of Candidemia in Swiss T ertiary Care Hospitals: Secular T rends, 1991-2000 · p. 1
C. albicans was the predominant Candida species recovered, accounting for 66% of isolates.
“C. albicans remained the predominant Candida species recovered (66%)”
Quote in the paperSubstantial claim- Rests on an assumption: The species identification methods remained consistent across hospitals and over the 10-year period.
- Findingown data§ RESULTS · p. 5
C. albicans remained the predominant species, accounting for 64%-68% of all isolates recovered.
“C. albicans remained the predominant species, ranging between 64% and 68% of all isolates recovered”
Quote in the paperNot a substantial claim - Findingown data§ RESULTS · p. 4
These 6 centers reported 774 (68%) of all 1137 episodes of candidemia recorded in the survey over 10 years.
“These 6 centers reported 774 (68%) of all 1137 episodes of candidemia recorded in the survey over 10 years.”
Quote in the paperNot a substantial claim - Findingown data§ Epidemiology of Candidemia in Swiss T ertiary Care Hospitals: Secular T rends, 1991-2000 · p. 1
C. tropicalis emerged, accounting for 9%.
“Candida tropicalis emerged (9%)”
Quote in the paperNot a substantial claim- Rests on an assumption: The species identification methods remained consistent across hospitals and over the 10-year period.
- Findingnone given§ Epidemiology of Candidemia in Swiss T ertiary Care Hospitals: Secular T rends, 1991-2000 · p. 1
Fluconazole consumption increased significantly during the study period.
“Fluconazole consumption increased significantly ( ).”
Quote in the paperNot a substantial claim- Rests on an assumption: Fluconazole consumption data from the representative sample reflect national fluconazole consumption in Swiss tertiary care hospitals.
- Findingown data§ Epidemiology of Candidemia in Swiss T ertiary Care Hospitals: Secular T rends, 1991-2000 · p. 1
The incidence of candidemia was stable over the 10-year period.
“The incidence of candidemia was stable over a 10-year period.”
Quote in the paperSubstantial claim- Rests on an assumption: The participating hospitals' candidemia surveillance data are complete and accurate for the study period.
- Rests on an assumption: The species identification methods remained consistent across hospitals and over the 10-year period.
- Findingown data§ DISCUSSION · p. 7
In 2000, candidemia incidence in ICUs was sevenfold higher than in wards (2.36 vs 0.33 episodes per 10,000 patient-days).
“In 2000, we observed a 7-fold higher incidence of candidemia in ICUs (2.36 episodes per 10,000 patient-days) than in wards (0.33 episodes per 10,000 patient-days).”
Quote in the paperNot a substantial claim - Findingown data§ DISCUSSION · p. 8
Fluconazole use in six university and university-affiliated hospitals increased fourfold, from 7.3 to 30 g per 10,000 patient-days between 1991 and 2000.
“the use of fluconazole in 6 university and university-affiliated hospitals increased 4-fold, from 7.3 to 30 g per 10,000 patient-days in 1991 and 2000, respectively.”
Quote in the paperSubstantial claim - Findingown data§ RESULTS · p. 5
No resistance to amphotericin B or 5-flucytosine was observed in 1999-2000 among 35 and 29 Candida isolates, respectively.
“No resistance to amphotericin B and 5-flucytosine was observed in 1999-2000 in 35 and 29 Candida isolates, respectively.”
Quote in the paperNot a substantial claim - Findingown data§ RESULTS · p. 5
During 1997-1998, 5 (24%) of 21 non-albicans Candida isolates were fluconazole-resistant, including 4 C. glabrata and 1 C. krusei.
“During 1997-1998, a similar proportion of fluconazole-resistant nonalbicans isolates of Candida was reported (5 [24%] of 21 isolates, of which 4 were C. glabrata and 1 was C. krusei )”
Quote in the paperSubstantial claim - Findingown data§ DISCUSSION · p. 7
In Switzerland, no shift to azole-resistant Candida species was observed over the 10-year period.
“In Switzerland, no shift to azole-resistant Candida species was observed over a 10-year period.”
Quote in the paperSubstantial claim - Premisecitation§ Epidemiology of Candidemia in Swiss T ertiary Care Hospitals: Secular T rends, 1991-2000 · p. 2
Few comprehensive epidemiological data on candidemia are available from European hospitals.
“Few comprehensive epidemiological data are available from European hospitals [13, 14].”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationreasoning§ Epidemiology of Candidemia in Swiss T ertiary Care Hospitals: Secular T rends, 1991-2000 · p. 2
The epidemiology of candidemia in Europe might differ from that in the United States.
“These observations suggest that the epidemiology of candidemia in Europe might differ from that in the United States.”
Quote in the paperSubstantial claim - Interpretationown data§ Epidemiology of Candidemia in Swiss T ertiary Care Hospitals: Secular T rends, 1991-2000 · p. 1
No shift to resistant Candida species occurred.
“no shift to resistant species occurred.”
Quote in the paperSubstantial claim- Rests on an assumption: The species identification methods remained consistent across hospitals and over the 10-year period.
- Study design and conductreasoning§ RESULTS · p. 5
Ten-year trends in antifungal susceptibility are unavailable because susceptibility testing became common only in the late 1990s.
“Because antifungal susceptibility testing became common practice only during the late 1990s, data on 10-year trends are not available.”
Quote in the paperNot a substantial claim - Interpretationown data§ DISCUSSION · p. 6
No change in candidemia incidence occurred despite an increasing number of high-risk clinical settings.
“no change in the incidence of candidemia occurred, despite an increasing number of high-risk clinical settings.”
Quote in the paperSubstantial claim - Interpretationreasoning§ DISCUSSION · p. 8
The association between rising fluconazole use and constant candidemia incidence suggests that prophylactic, preemptive, or empirical strategies in high-risk settings may have helped stabilize the disease incidence.
“The association between the progressive rise in fluconazole use and the constant incidence of candidemia suggests that prophylactic and preemptive and/or empirical strategies in high-risk clinical settings might have played a role in stabilizing the incidence of the disease”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [2931]
Not checked in the free run.
- Interpretationown data§ RESULTS · p. 5
The rate of azole resistance did not increase during 1997-2000.
“suggesting that the rate of azole resistance did not increase during 1997-2000.”
Quote in the paperNot a substantial claim - Interpretationown data§ DISCUSSION · p. 8
Increased fluconazole use did not influence the distribution of Candida species during the 10-year study period.
“The increased use of fluconazole did not influence the distribution of the different Candida species during the 10-year period under study.”
Quote in the paperSubstantial claim - Interpretationown data§ DISCUSSION · p. 6
The increase in blood cultures and transplantations represents an increased number of clinical settings at high risk for candidemia.
“representing an increased number of clinical settings at high risk for candidemia.”
Quote in the paperNot a substantial claim - Premisecitation§ DISCUSSION · p. 7
In 1989, the NNIS system described rates 2- to 3-fold higher than those in Switzerland: 0.61 and 0.37 episodes per 1000 discharges in large and small US teaching hospitals.
“In 1989, the NNIS system described 2- to 3-fold higher rates0.61 and 0.37 episodes per 1000 discharges in large ( 1 500-bed) and small ( ! 500-bed) US teaching hospitals, respectively [5].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [5] source
Not checked in the free run.
- Premisecitation§ DISCUSSION · p. 7
This phenomenon was not described in other studies from Canada, Latin America, and Europe.
“However, this phenomenon was not described in other studies from Canada, Latin America, and Europe [15, 27].”
Quote in the paperNot a substantial claim0 of 2 sources checked
- May combine two claims. 30
- The quote only partly states this claim. 5
- Classified as probably not a substantial claim. 24
May combine two claims.
Findingown data§ RESULTS · p. 4In the 6 centers with longitudinal data, 533,490 blood cultures were performed over 10 years, of which 52,565 (9.8%) were positive.
“In these institutions, 533,490 blood cultures were performed over a 10-year period. Of these, 52,565 (9.8%) were positive (i.e., cultures yielded any pathogen).”
Quote in the paperNot a substantial claimMay combine two claims. The quote only partly states this claim.
Findingown data§ RESULTS · p. 5The overall proportion of non-albicans Candida species was 36% in university hospitals and 31% in university-affiliated hospitals, a non-significant difference.
“the overall proportion of nonalbicans species of Candida was 36% in university hospitals and 31% in universityaffiliated hospitals ( ).”
Quote in the paperNot a substantial claimThe quote only partly states this claim.
Findingown data§ RESULTS · p. 4No significant difference was observed between university and university-affiliated institutions in the distribution of Candida isolates by hospital sector.
“No significant difference was observed between university and university-affiliated institutions.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data§ Epidemiology of Candidemia in Swiss T ertiary Care Hospitals: Secular T rends, 1991-2000 · p. 1The incidence of C. parapsilosis decreased, accounting for 1%.
“the incidence of Candida parapsilosis decreased (1%)”
Quote in the paperNot a substantial claim- Rests on an assumption: The species identification methods remained consistent across hospitals and over the 10-year period.
May combine two claims.
Findingown data§ RESULTS · p. 5Fluconazole administration increased progressively for both parenteral and oral forms during 1991-2000.
“A progressive increase in the quantities of the parenteral and oral forms that were administered was observed.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data§ RESULTS · p. 3Most cases of acute leukemia (71%) and transplantations (92%) were reported by university hospitals in 2000.
“In 2000, most cases of acute leukemia (71%) and transplantations (92%) were reported by university hospitals.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data§ Epidemiology of Candidemia in Swiss T ertiary Care Hospitals: Secular T rends, 1991-2000 · p. 1C. glabrata was the second most common species, accounting for 15%.
“followed by C. glabrata (15%)”
Quote in the paperNot a substantial claim- Rests on an assumption: The species identification methods remained consistent across hospitals and over the 10-year period.
May combine two claims. The quote only partly states this claim.
Findingown data§ DISCUSSION · p. 7C. parapsilosis decreased from 6% during 1991-1993 to 1% during 2000, a significant change.
“that of Candida parapsilosis decreased from 6% to 1% ( )”
Quote in the paperSubstantial claimThe quote only partly states this claim.
Findingown data§ RESULTS · p. 3The overall incidence of candidemia in 2000 was 0.49 cases per 10,000 patient-days.
“The overall incidence of infection was 0.49 cases per 10,000 patient-days.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data§ RESULTS · p. 5C. glabrata was the second most common species recovered, at 14% during 1991-1993 and 15% during 2000.
“C. glabrata was the second most common species recovered (14% during 1991-1993 and 15% during 2000).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data§ Epidemiology of Candidemia in Swiss T ertiary Care Hospitals: Secular T rends, 1991-2000 · p. 1Candida species ranked seventh among etiologic agents of bloodstream infections, accounting for 2.9% of all bloodstream isolates.
“Candida species ranked seventh among etiologic agents (2.9% of all bloodstream isolates).”
- Also stated in: § RESULTS · p. 4 · plain
“Candida species accounted for 2.9% of the bloodstream pathogens (median annual proportion, 2.8%; range, 2.3%-3.4%) and ranked seventh”
Quote in the paperNot a substantial claim- Also stated in: § RESULTS · p. 4 · plain
May combine two claims. The quote only partly states this claim.
Findingown data§ DISCUSSION · p. 7C. tropicalis increased from 2% during 1991-1993 to 9% during 2000, a significant change.
“The proportion of Candida tropicalis increased from 2% to 9% ( )”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data§ DISCUSSION · p. 6The number of blood cultures and transplantations performed increased significantly during the study period.
“The analysis of hospital characteristics and activities shows a significant increase in the number of blood cultures and transplantations performed”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data§ RESULTS · p. 5Resistant non-albicans isolates included 5 C. glabrata, 1 C. krusei, 1 C. norvegiensis, and 1 C. tropicalis.
“Resistant nonalbicans isolates of Candida included 5 C. glabrata isolates, 1 C. krusei isolate, 1 Candida norvegiensis isolate, and 1 C. tropicalis isolate.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data§ RESULTS · p. 5In 1991, 2.1 g per 10,000 patient-days of fluconazole was given intravenously and 5.2 g orally; in 2000, the corresponding amounts were 12.2 g and 17.8 g.
“In 1991, 2.1 and 5.2 g per 10,000 patient-days were administered intravenously and orally, respectively; in 2000, 12.2 and 17.8 g per 10,000 patient-days were administered, respectively”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data§ DISCUSSION · p. 6Candida organisms ranked sixth through ninth among recovered bloodstream pathogens and accounted for 2%-3% of all isolates during the study period.
“Candida organisms ranged from the sixth through ninth most recovered bloodstream pathogens and accounted for 2%-3% of all isolates during this period.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingnone given§ DISCUSSION · p. 7One-third of all candidemia episodes occurred in ICUs, one-third in medical wards (including hemato-oncology units), and one-fourth in surgical wards.
“In Switzerland, one-third of all episodes of candidemia occurred in ICUs, onethird in medical wards (including hemato-oncology units), and one-fourth in surgical wards.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data§ RESULTS · p. 5In 1999-2000, fluconazole susceptibility data were available for 96 (39%) of 245 Candida isolates: 90 (60%) of 151 isolates from university hospitals and 6 (6%) of 94 from university-affiliated hospitals.
“In 1999-2000, data on fluconazole susceptibility were available for 96 (39%) of 245 Candida isolates, comprising 90 (60%) of 151 isolates from university hospitals and 6 (6%) of 94 from university-affiliated hospitals ( ).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data§ DISCUSSION · p. 7In 2000, incidence was 0.54 episodes per 10,000 patient-days (0.36 per 1000 admissions) in university hospitals and 0.40 episodes per 10,000 patient-days (0.15 per 1000 admissions) in university-affiliated hospitals.
“In 2000, 0.54 episodes per 10,000 patient-days (0.36 episodes per 1000 hospital admissions) and 0.40 episodes per 10,000 patient-days (0.15 episodes per 1000 hospital admissions) were reported in university and university-affiliated hospitals, respectively.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown data§ Epidemiology of Candidemia in Swiss T ertiary Care Hospitals: Secular T rends, 1991-2000 · p. 1The survey included 17 university and university-affiliated hospitals representing 79% of all tertiary care hospital beds in Switzerland.
“We conducted a nationwide survey of candidemia during 1991-2000 in 17 university and university-affiliated hospitals representing 79% of all tertiary care hospital beds in Switzerland.”
- Also stated in: § RESULTS · p. 2 · plain
“A total of 9333 beds representing 79% of all tertiary care hospital beds in Switzerland were included in the survey”
Quote in the paperSubstantial claim- Also stated in: § RESULTS · p. 2 · plain
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone given§ METHODS · p. 2The participating institutions serve the majority of the Swiss population (84%).
“These institutions are distributed across the country and play a key role in the national health care system by serving the majority of the population of Switzerland ( ∼ 6,100,000 [84%] of 7,200,000 residents).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductcitation§ METHODS · p. 2All laboratories used automated blood culture systems and recognized standard laboratory techniques for Candida species identification.
“All laboratories used automated blood culture systems (12 used Bactec [Becton Dickinson] and 5 used BacT/Alert [bioMe ´rieux]), and 7 (44%) of 16 used special blood culture bottles for fungus detection (5 used Bactec Mycosis IC/F vials [Becton Dickinson] and 2 used other types). Recognized standard laboratory techniques for Candida species identification were used by all laboratories [16].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [16] Warren N, Hazen K. Candida, Cryptococcus, and other yeasts of medical importance. In: Murray PR, ed. Manual of clinical microbiology. Washington, DC: ASM Press, 1999:1184-1199.
Not checked in the free run.
May combine two claims.
Study design and conductnone given§ METHODS · p. 2All Swiss university hospitals and a representative sample of university-affiliated tertiary care teaching centers were included in the survey.
“All Swiss university hospitals (5 health care centers and 2 independent pediatric hospitals) and a representative sample of university-affiliated tertiary care teaching centers ( ) were included in a retrospective surn p 11 vey.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Study design and conductnone given§ METHODS · p. 2All hematopoietic stem cell and solid-organ transplantations are performed in these centers.
“All hematopoietic stem cell and solid-organ transplantations are performed in these centers”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone given§ METHODS · p. 2Returned questionnaires were checked for completeness and consistency, and those with missing data or inconsistencies were returned for correction.
“Returned questionnaires (from 17 of the 18 hospitals) were checked by the survey coordinators for completeness and consistency. Those with missing data or inconsistencies were returned for completion and/or correction.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductcitation§ METHODS · p. 2Antifungal susceptibility testing was performed in 7 (44%) of 16 laboratories, with quality control based on NCCLS recommendations.
“Antifungal susceptibility testing, the quality control of which was based on NCCLS recommendations, was performed in 7 (44%) of 16 laboratories [17].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [17] NCCLS. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. NCCLS document M27-A. Villanova, PA: NCCLS, 1997.
Not checked in the free run.
May combine two claims.
Study design and conductnone given§ DISCUSSION · p. 8The study provides a longitudinal overview of secular trends associated with patient-care activities and is representative of the entire country over a 10-year period.
“It provides a longitudinal overview of the secular trends associated with patient-care activities, which is representative of the entire country over a 10-year period.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ DISCUSSION · p. 6A similar evolution was observed in Asia.
“A similar evolution was observed in Asia [18].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [18] Chen YC, 1997, Infect Control Hosp Epidemiol source
Not checked in the free run.
May combine two claims.
Study design and conductnone given§ DISCUSSION · p. 8Despite the absence of a centralized laboratory, this retrospective study is the largest European series of candidemia and one of the largest worldwide.
“Despite the lack of a centralized laboratory, this retrospective study represents the largest European series of candidemia and one of the largest worldwide.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown data§ DISCUSSION · p. 8Candidemia incidence remained stable despite increasing high-risk activities, and no shift to azole-resistant Candida species was observed.
“The incidence of candidemia remained stable, despite increasing high-risk activities, and no shift to azole-resistant Candida species was observed.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Interpretationnone given§ DISCUSSION · p. 8Improved infection-control practices may have contributed to stabilizing candidemia incidence despite an increase in high-risk patient-care activities.
“On the other hand, improved infection-control practices might have contributed to such stabilization, despite an increase of high-risk patient-care activities.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ DISCUSSION · p. 6Invasive candidiasis became a major problem in US hospitals during the 1980s.
“Invasive candidiasis emerged as a major problem in US hospitals in the 1980s [5, 7].”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ DISCUSSION · p. 6An inverse trend occurred during 1989-1999 among ICUs in US hospitals reporting to the NNIS system.
“However, an inverse trend was observed during 19891999 among ICUs in US hospitals reporting to the NNIS system [8].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [8] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone given§ DISCUSSION · p. 7The emergence of Candida species with decreased susceptibility or intrinsic resistance to azoles was a major concern in the 1990s.
“The emergence of Candida species with decreased susceptibility or intrinsic resistance to azoles was a major concern in the 1990s.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ DISCUSSION · p. 7Other North American and European investigators confirmed these observations in larger hospital settings.
“Other North American and European investigators confirmed these observations in larger hospital settings [10, 11, 13, 20, 22, 25, 26].”
Quote in the paperNot a substantial claim0 of 7 sources checked- cites [10] Abi-Said D, 1997, Clin Infect Dis source
Not checked in the free run.
- cites [11] Viscoli C, 1999, Clin Infect Dis source
Not checked in the free run.
- cites [13] source
Not checked in the free run.
- cites [20] Berrouane YF, 1999, J Clin Microbiol source
Not checked in the free run.
- cites [22] source
Not checked in the free run.
- cites [25] source
Not checked in the free run.
- cites [26] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ DISCUSSION · p. 7This phenomenon was first reported in the United States in neutropenic recipients of bone marrow transplants.
“This phenomenon was first reported in the United States in neutropenic recipients of bone marrow transplants [9].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [9] Wingard JR, 1991, N Engl J Med source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone given§ DISCUSSION · p. 6Other recent multicenter longitudinal data from Europe are lacking.
“Other recent multicenter longitudinal data from Europe are lacking.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ DISCUSSION · p. 7Ten years later, Berrouane et al. observed 0.98 episodes of candidemia per 10,000 patient-days in one US tertiary care center.
“Ten years later, Berrouane et al. [20] observed 0.98 episodes of candidemia per 10,000 patient-days in 1 US tertiary care center.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [20] Berrouane YF, 1999, J Clin Microbiol source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ DISCUSSION · p. 6No significant change was reported in one Swiss hospital between 1989 and 2000.
“No significant change was reported in 1 Swiss hospital between 1989 and 2000 [19].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [19] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisecitation§ DISCUSSION · p. 6In Europe, contrasting data were reported in the early 1990s: candidemia incidence increased in The Netherlands and remained stable in Norway.
“In Europe, contrasting data were reported in the early 1990s-the incidence of candidemia increased in The Netherlands and remained stable in Norway [13, 15].”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ DISCUSSION · p. 7The distribution of Candida species plays a key role in establishing efficient management strategies.
“The distribution of Candida species plays a key role for establishing efficient management strategies [23, 24].”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisecitation§ DISCUSSION · p. 8A study from one Swiss university hospital reported no shift to non-albicans Candida species despite a significant increase in fluconazole use between 1989 and 2000.
“In contrast, a study from 1 Swiss university hospital reported no shift to nonalbicans species of Candida, despite a significant increase in fluconazole use between 1989 and 2000 [19].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [19] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ DISCUSSION · p. 8The role of widespread azole use in the shift to resistant Candida species has been largely debated and remains controversial.
“The role of the widespread use of azoles in the shift to resistant Candida species has been largely debated and remains controversial [12].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [12] White MH, 1997, Clin Infect Dis source
Not checked in the free run.
May combine two claims.
Premisecitation§ DISCUSSION · p. 7The species distributions were very close to those reported in Norway during the early 1990s, in Italy during an ECCM survey in the late 1990s, and in Wales.
“The species distributions were very close to those reported in Norway during the early 1990s, in Italy during an ECCM survey conducted in the late 1990s, and in Wales [15, 22, 28].”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisecitation§ DISCUSSION · p. 8Two groups observed an important increase of C. glabrata fungemia in the 1990s and analyzed fluconazole consumption over time.
“Two groups observed an important increase of C. glabrata fungemia in the 1990s and analyzed fluconazole consumption over time.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ DISCUSSION · p. 7Trick et al. recently confirmed these trends in patients in US ICUs.
“Trick et al. [8] recently confirmed these trends in patients in US ICUs.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [8] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ DISCUSSION · p. 8Voss et al. evaluated annual nationwide fluconazole use in The Netherlands in kilograms and observed a fourfold increase between 1990 and 1995.
“Voss et al. [13] evaluated the annual nationwide fluconazole use in The Netherlands in kilograms and observed a 4-fold increase between 1990 and 1995.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [13] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ DISCUSSION · p. 8Berrouane et al. observed a substantial increase in fluconazole use, from 3 to 33 g per 10,000 patient-days in 1990 and 1994, respectively.
“Similarly, Berrouane et al. [20] observed a substantial increase in fluconazole use, from 3 to 33 g per 10,000 patient-days in 1990 and 1994, respectively.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [20] Berrouane YF, 1999, J Clin Microbiol source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Premisenone given§ DISCUSSION · p. 7In institutions where this shift occurred, proportions of C. glabrata and C. krusei were 15%-45% and 5%-20%, respectively.
“In institutions where this shift occurred, proportions of C. glabrata and C. krusei were 15%-45% and 5%20%, respectively.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
No recent longitudinal multicenter study on candidemia in Europe had been performed before this survey.
“to our knowledge, no recent longitudinal multicenter study has been performed in Europe.”
The paper relies on this without support.
The participating hospitals' candidemia surveillance data are complete and accurate for the study period.
“Data on the number of patient-days spent in the hospital, the transplantation activities, the number of blood cultures performed, the 10 most frequently recovered bloodstream isolates, and the consumption of fluconazole during 1991-2000 were additionally obtained from a representative sample of university and university-affiliated hospitals.”
The paper relies on this without support.
Blood culture practices and the number of blood cultures performed are valid indicators of the incidence of bloodstream infections.
“The number of transplantations and bloodstream infections increased significantly ( ).”
The paper relies on this without support.
Fluconazole consumption data from the representative sample reflect national fluconazole consumption in Swiss tertiary care hospitals.
“Fluconazole consumption increased significantly ( ).”
The paper relies on this without support.
The species identification methods remained consistent across hospitals and over the 10-year period.
“Recognized standard laboratory techniques for Candida species identification were used by all laboratories [16].”
The paper relies on this without support.
Critically ill and severely immunocompromised patients are at particularly high risk for invasive candidiasis.
“Critically ill and severely immunocompromised patients are at particularly high risk for invasive candidiasis.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
ICU candidiasis represent one-third of all invasive candidiasis and are associated with a high mortality rate.
“Overall, ICU candidiasis represent one-third of all invasive candidiasis and is associated with a high mortality rate [11].”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [11]
The C. guilliermondii isolates in the Masala et al. cluster shared a common DNA fingerprint, and nosocomial transmission stopped following reinforcement of infection control measures.
“The isolates shared a common DNA fingerprint, and nosocomial transmission stopped following reinforcement of infection control measures.”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [151]
Masala et al. reported a cluster of C. guilliermondii catheter-related BSIs among five surgical patients.
“Masala et al. (151) reported a cluster of C. guilliermondii catheter-related BSIs among five surgical patients.”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [151]
The C. guilliermondii catheter-related BSIs in the Masala et al. cluster were successfully treated with catheter removal and administration of fluconazole.
“The infections were successfully treated with catheter removal and administration of fluconazole.”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [151]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Conclusion denies a reported resistant C. albicans isolate
MajorThe discussion says no resistance was observed in C. albicans, but the susceptibility results report one resistant isolate. This directly contradicts a conclusion about resistance.
“Although fluconazole use increased significantly over the 10-year period, no shift toward azole-resistant nonalbicans species of Candida and no resistance in C. albicans were observed.”
“Fifty-six C. albicans isolates and 40 nonP ! .001 albicans isolates of Candida were tested for susceptibility to fluconazole, and 1 (2%) and 8 (20%) of the isolates, respectively, were resistant, according to the NCCLS criteria.”
Percentage with ward-location data is incorrect
MinorThe reported 92 patients out of 117 constitute 78.6%, which rounds to 79%, not 77%.
Reported 77 · recomputed 78.632479
“Data on the hospital ward distribution of 92 (77%) of all 117 patients with candidemia reported in 2000 were available from 10 hospitals.”
ICU percentage for 1991-1995 is overstated
MinorThe stated 109 ICU episodes out of 355 are 30.7%, which rounds to 31%, not 32%.
Reported 32 · recomputed 30.704225
“109 (32%) of 355 and 107 (35%) of”
Cites
Manual of Clinical Microbiology.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-6-939_2 · Cited by 14,435 · see citing works
Nosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P. (1999) · Clinical Infectious Diseases · doi:10.1086/520192 · Cited by 1,387 · see citing works
Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990
Beck‐Sagué, C. M., Jarvis, W. R., & System, N. N. I. S. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1247 · Cited by 1,140 · see citing works
Wingard, J. R., Merz, W. G., Rinaldi, M. G., Johnson, T. R., Karp, J. E., & Saral, R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110313251803 · Cited by 937 · see citing works
Practice Guidelines for the Treatment of Candidiasis
Rex, J. H., Walsh, T. J., Sobel, J. D., Filler, S. G., Pappas, P. G., Dismukes, W. E., & Edwards, J. E. (2000) · Clinical Infectious Diseases · doi:10.1086/313749 · Cited by 927 · see citing works
Secular trends in nosocomial primary bloodstream infections in the United States, 1980–1989.
Banerjee, S. N., Emori, T. G., Culver, D. H., Gaynes, R. P., Jarvis, W. R., Horan, T., Edwards, J. R., Tolson, J., Henderson, T., Martone, W. J., et al. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90349-3 · Cited by 880 · see citing works
Hospital-Acquired Candidemia: The Attributable Mortality and Excess Length of Stay
Wey, S. B. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380120094019 · Cited by 831 · see citing works
The Epidemiology of Hematogenous Candidiasis Caused by Different Candida Species
Abi‐Said, D., Anaissie, E., Uzun, O., Raad, I., Pinzcowski, H., & Vartivarian, S. (1997) · Clinical Infectious Diseases · doi:10.1086/513663 · Cited by 755 · see citing works
Trick, W. E., Fridkin, S. K., Edwards, J. R., Hajjeh, R. A., Gaynes, R. P., & Hospitals, T. N. N. I. S. S. (2002) · Clinical Infectious Diseases · doi:10.1086/342300 · Cited by 660 · see citing works
Viscoli, C., Girmenia, C., Marinus, A., Collette, L., Martino, P., Vandercam, B., Doyen, C., Lebeau, B., Spence, D., Krcmery, V., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/514731 · Cited by 601 · see citing works
Marr, K. A., Seidel, K., White, T. C., & Bowden, R. A. (2000) · The Journal of Infectious Diseases · doi:10.1086/315193 · Cited by 493 · see citing works
Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients
Eggimann, P., Francioli, P., Bille, J., Schneider, R., Wu, M.-M., Chapuis, G., Chiolero, R., Pannatier, A., Schilling, J., Geroulanos, S., et al. (1999) · Critical Care Medicine · doi:10.1097/00003246-199906000-00019 · Cited by 414 · see citing works
Self-citationPfaller, M. A., Jones, R. N., Doern, G. V., Sader, H. S., Messer, S. A., Houston, A., Coffman, S., Hollis, R. J., & The SENTRY Participant Group (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.747-751.2000 · Cited by 378 · see citing works
Fluit, A. C., Jones, M. E., Schmitz, F.-J., Acar, J., Gupta, R., Verhoef, J., & the SENTRY Participants Group (2000) · Clinical Infectious Diseases · doi:10.1086/313710 · Cited by 312 · see citing works
The Impact of Candidemia on Length of Hospital Stay, Outcome, and Overall Cost of Illness
Rentz, A. M., Halpern, M. T., & Bowden, R. (1998) · Clinical Infectious Diseases · doi:10.1086/514955 · Cited by 310 · cited 1× · see citing works
“tial health care costs [1–4].”
Pittet, D., Li, N., Woolson, R. F., & Wenzel, R. P. (1997) · Clinical Infectious Diseases · doi:10.1086/513640 · Cited by 295 · see citing works
Self-citationPfaller, M. A., & Diekema, D. J. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.10.3551-3557.2002 · Cited by 269 · see citing works
Garbino, J., Lew, D. P., Romand, J.-A., Hugonnet, S., Auckenthaler, R., & Pittet, D. (2002) · Intensive Care Medicine · doi:10.1007/s00134-002-1540-y · Cited by 247 · see citing works
Self-citationCLINICAL SIGNIFICANCE OF CANDIDA ISOLATED FROM PERITONEUM IN SURGICAL PATIENTS
Calandra, T., Schneider, R., Billé, J., Mosimann, F., & Francioli, P. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92043-6 · Cited by 237 · see citing works
Self-citationWhite, M. H. (1997) · Clinical Infectious Diseases · doi:10.1086/513661 · Cited by 151 · see citing works
Secular Trends of Candidemia Over 12 Years in Adult Patients at a Tertiary Care Hospital
GARBINO, J., KOLAROVA, L., ROHNER, P., LEW, D., PICHNA, P., & PITTET, D. (2002) · Medicine · doi:10.1097/00005792-200211000-00003 · Cited by 143 · see citing works
Self-citationTrends in Antifungal Use and Epidemiology of Nosocomial Yeast Infections in a University Hospital
Berrouane, Y. F., Herwaldt, L. A., & Pfaller, M. A. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.3.531-537.1999 · Cited by 136 · see citing works
St-Germain, G., Laverdière, M., Pelletier, R., Bourgault, A.-M., Libman, M., Lemieux, C., & Noël, G. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.3.949-953.2001 · Cited by 134 · see citing works
Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch university hospitals
Voss, A., Kluytmans, J. A. J. W., Koeleman, J. G. M., Spanjaard, L., Vandenbroucke-Grauls, C. M. J. E., Verbrugh, H. A., Vos, M. C., Weersink, A. Y. L., Hoogkamp-Korstanje, J. A. A., & Meis, J. F. G. M. (1996) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01690507 · Cited by 128 · see citing works
Candidemia in French hospitals: incidence rates and characteristics
Richet, H., Roux, P., de Champs, C., Esnault, Y., & Andremont, A. (2002) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2002.00446.x · Cited by 120 · see citing works
Tortorano, A. M., Biraghi, E., Astolfi, A., Ossi, C., Tejada, M., Farina, C., Perin, S., Bonaccorso, C., Cavanna, C., Raballo, A., et al. (2002) · Journal of Hospital Infection · doi:10.1053/jhin.2002.1261 · Cited by 116 · see citing works
Pittet, D. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.11.1177 · Cited by 115 · see citing works
Self-citationEmerging trends in the epidemiology of invasive mycoses in England and Wales (1990–9)
LAMAGNI, T. L., EVANS, B. G., SHIGEMATSU, M., & JOHNSON, E. M. (2001) · Epidemiology and Infection · doi:10.1017/s0950268801005507 · Cited by 104 · see citing works
Trick, W. E., & Fridkin, S. K. (2002) · Cited by 103 · see citing works
Nettleman, M. D., Chen, Y.-C., Chang, S.-C., Sun, C.-C., Yang, L.-S., Hsieh, W.-C., & Luh, K.-T. (1997) · Infection Control & Hospital Epidemiology · doi:10.1086/647628 · Cited by 88 · see citing works
Constant Low Rate of Fungemia in Norway, 1991 to 1996
Sandven, P., Bevanger, L., Digranes, A., Gaustad, P., Haukland, H. H., Steinbakk, M., & The Norwegian Yeast Study Group (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.12.3455-3459.1998 · Cited by 82 · see citing works
Nosocomial bloodstream infection
Mer, M. (2005) · Southern African Journal of Epidemiology and Infection · doi:10.1080/10158782.2005.11441235 · Cited by 16 · see citing works
Flagged first, then by citations
2 of the 34 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Beck-Sague CM, 1993, The National Nosocomial Infection Surveillance System. J Infect Dis, 167, 1247
Cited by
Sorted by citations
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · see citing works
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191 · see citing works
Self-citationHorn, D. L., Neofytos, D., Anaissie, E. J., Fishman, J. A., Steinbach, W. J., Olyaei, A. J., Marr, K. A., Pfaller, M. A., Chang, C., & Webster, K. M. (2009) · Clinical Infectious Diseases · doi:10.1086/599039 · Cited by 956 · see citing works
Epidemiology of Candida species infections in critically ill non-immunosuppressed patients
Eggimann, P., Garbino, J., & Pittet, D. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00801-6 · Cited by 900 · see citing works
Self-citationKampf, G., & Krämer, A. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.4.863-893.2004 · Cited by 760 · see citing works
Epidemiology and risk factors for invasive candidiasis
Yapar, N. (2014) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s40160 · Cited by 610 · see citing works
Almirante, B., Rodríguez-Pardo, D., Park, B. J., Cuenca‐Estrella, M., Planes, A. M., Almela, M., Mensa, J., Sánchez, F., Ayats, J., Giménez, M., et al. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.4.1829-1835.2005 · Cited by 567 · see citing works
Leroy, O., Gangneux, J., Montravers, P., Mira, J. P., Gouin, F., Sollet, J.-P., Carlet, J. M., Reynes, J., Rosenheim, M., Regnier, B., et al. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819efac0 · Cited by 536 · see citing works
Colombo, A. L., Nucci, M., Park, B. J., Nouér, S. A., Arthington, B. A., da Matta, D. A., Warnock, D. W., & Morgan, J. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00773-06 · Cited by 525 · see citing works
Invasive candidiasis as a cause of sepsis in the critically ill patient
Delaloye, J., & Calandra, T. (2013) · Virulence · doi:10.4161/viru.26187 · Cited by 380 · see citing works
Self-citationEpidemiology of invasive candidiasis
Arendrup, M. C. (2010) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32833e84d2 · Cited by 376 · see citing works
Epidemiology of candidemia in Latin America: a laboratory-based survey
Nucci, M., Queiroz-Telles, F., Alvarado-Matute, T., Tiraboschi, I. N., Cortes, J., Zurita, J., Guzman-Blanco, M., Santolaya, M. E., Thompson, L., Sifuentes-Osornio, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059373 · Cited by 374 · see citing works
The changing face of epidemiology of invasive fungal disease in Europe
Lass‐Flörl, C. (2009) · Mycoses · doi:10.1111/j.1439-0507.2009.01691.x · Cited by 365 · see citing works
Lortholary, O., Desnos-Ollivier, M., Sitbon, K., Fontanet, A., Bretagne, S., & Dromer, F. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01128-10 · Cited by 362 · see citing works
Candidaemia in Europe: epidemiology and resistance
Tortorano, A. M., Kibbler, C. C., Pemán, J., Bernhardt, H., Klingspor, L., & Grillot, R. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.01.002 · Cited by 349 · see citing works
Falagas, M. E., Ρούσσος, Ν., & Vardakas, K. Z. (2010) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2010.04.006 · Cited by 346 · see citing works
Tumbarello, M., Posteraro, B., Trecarichi, E. M., Fiori, B., Rossi, M., Porta, R., de Gaetano Donati, K., La Sorda, M., Spanu, T., Fadda, G., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00131-07 · Cited by 343 · see citing works
Nosocomial Fungal Infections: Epidemiology, Infection Control, and Prevention
Alangaden, G. J. (2011) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2010.11.003 · Cited by 337 · see citing works
Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis
Koehler, P., Stecher, M., Cornely, O. A., Koehler, D., Vehreschild, M. J. G. T., Bohlius, J., Wisplinghoff, H., & Vehreschild, J. J. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.04.024 · Cited by 336 · see citing works
Epidemiological trends in nosocomial candidemia in intensive care
Bassetti, M., Righi, E., Costa, A., Fasce, R., Molinari, M. P., Rosso, R., Pallavicini, F. B., & Viscoli, C. (2006) · BMC Infectious Diseases · doi:10.1186/1471-2334-6-21 · Cited by 332 · see citing works
Hochreiter, M., Köhler, T., Schweiger, A. M., Keck, F. S., Bein, B., von Spiegel, T., & Schroeder, S. (2009) · Critical Care · doi:10.1186/cc7903 · Cited by 315 · see citing works
The French Mycosis Study Group, Lortholary, O., Renaudat, C., Sitbon, K., Madec, Y., Denoeud‐Ndam, L., Wolff, M., Fontanet, A. L., Bretagne, S., & Dromer, F. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3408-3 · Cited by 310 · see citing works
Puig‐Asensio, M., Padilla, B., Garnacho‐Montero, J., Zaragoza, Ó., Aguado, J. M., Zaragoza, R., Montejo, M., Muñóz, P., Ruíz-Camps, I., Cuenca‐Estrella, M., et al. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12380 · Cited by 297 · see citing works
A multicenter study of septic shock due to candidemia: Outcomes and predictors of mortality.
Bassetti, M., Righi, E., Ansaldi, F., Merelli, M., Cecilia, T., De Pascale, G., Diaz-Martin, A., Luzzati, R., Rosin, C., Lagunes, L., et al. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3310-z · Cited by 284 · see citing works
Epidemiology of opportunistic fungal infections in Latin America
Nucci, M., Queiroz‐Telles, F., Tobón, A. M., Restrepo, A., & Colombo, A. L. (2010) · Clinical Infectious Diseases · doi:10.1086/655683 · Cited by 280 · see citing works
Candidemia and invasive candidiasis in adults: A narrative review
Antinori, S., Milazzo, L., Sollima, S., Galli, M., & Corbellino, M. (2016) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2016.06.029 · Cited by 259 · see citing works
Patients at High Risk of Invasive Fungal Infections
Rüping, M. J. G. T., Vehreschild, J. J., & Cornely, O. A. (2008) · Drugs · doi:10.2165/00003495-200868140-00002 · Cited by 248 · see citing works
Invasive candidiasis in the intensive care unit
Ostrosky-Zeichner, L., & Pappas, P. G. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000201897.78123.44 · Cited by 247 · see citing works
Almirante, B., Rodríguez-Pardo, D., Cuenca‐Estrella, M., Almela, M., Sánchez, F., Ayats, J., Alonso-Tarrés, C., Rodrı́guez-Tudela, J. L., Pahissa, A., & the Barcelona Candidemia Project Study Group (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.5.1681-1685.2006 · Cited by 240 · see citing works
Schröder, S., Hochreiter, M., Koehler, T., Schweiger, A. M., Bein, B., Keck, F. S., & von Spiegel, T. (2008) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-008-0432-1 · Cited by 237 · see citing works
Bassetti, M., Merelli, M., Righi, E., Diaz-Martin, A., Rosello, E. M., Luzzati, R., Parra, A., Trecarichi, E. M., Sanguinetti, M., Posteraro, B., et al. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.01998-13 · Cited by 228 · see citing works
Schmiedel, Y., & Zimmerli, S. (2016) · Swiss Medical Weekly · doi:10.4414/smw.2016.14281 · Cited by 226 · see citing works
Pappas, P. G. (2006) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2006.07.004 · Cited by 226 · see citing works
Trends in the Epidemiology of Invasive Fungal Infections
Warnock, D. W. (2007) · Nippon Ishinkin Gakkai Zasshi · doi:10.3314/jjmm.48.1 · Cited by 222 · see citing works
Bench-to-bedside review: Candida infections in the intensive care unit
Méan, M., Marchetti, O., & Calandra, T. (2008) · Critical Care · doi:10.1186/cc6212 · Cited by 217 · see citing works
Self-citationBassetti, M., Taramasso, L., Nicco, E., Molinari, M. P., Mussap, M., & Viscoli, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024198 · Cited by 215 · see citing works
β-Glucan Antigenemia Anticipates Diagnosis of Blood Culture–Negative Intraabdominal Candidiasis
Tissot, F., Lamoth, F., Hauser, P. M., Orasch, C., Flückiger, U. M., Siegemund, M., Zimmerli, S., Calandra, T., Billé, J., Eggimann, P., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201211-2069oc · Cited by 204 · see citing works
Self-citationInvasive candidiasis: current clinical challenges and unmet needs in adult populations
Soriano, À., Honoré, P. M., Puerta‐Alcalde, P., García‐Vidal, C., Pagotto, A., Gonçalves, D. C., & Verweij, P. E. (2023) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkad139 · Cited by 200 · see citing works
Antimicrobial therapy for patients with severe sepsis and septic shock: An evidence-based review
Bochud, P., Bonten, M. J. M., Marchetti, O., & Calandra, T. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000143118.41100.14 · Cited by 195 · see citing works
Self-citationInitial antimicrobial management of sepsis
Niederman, M. S., Baron, R. M., Bouadma, L., Calandra, T., Daneman, N., Waele, J. J. D., Kollef, M. H., Lipman, J., & NAIR, G. B. (2021) · Critical Care · doi:10.1186/s13054-021-03736-w · Cited by 190 · see citing works
Self-citationFluconazole for the management of invasive candidiasis: where do we stand after 15 years?
Charlier, C., Hart, E. J., Lefort, A., Ribaud, P., Dromer, F., Denning, D. W., & Lortholary, O. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki473 · Cited by 187 · see citing works
Posteraro, B., PASCALE, G. D., Tumbarello, M., Torelli, R., Pennisi, M. A., Bello, G., Maviglia, R., Fadda, G., Sanguinetti, M., & Antonelli, M. M. (2011) · Critical Care · doi:10.1186/cc10507 · Cited by 184 · see citing works
Arendrup, M. C., Fuursted, K., Gahrn-Hansen, B., Jensen, I. M., Knudsen, J. D., Lundgren, B., Schønheyder, H. C., & Tvede, M. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.9.4434-4440.2005 · Cited by 177 · see citing works
One year prospective survey of Candida bloodstream infections in Scotland
Odds, F. C., Hanson, M. F., Davidson, A. D., Jacobsen, M. D., Wright, P., Whyte, J. A., Gow, N. A. R., & Jones, B. L. (2007) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47239-0 · Cited by 176 · see citing works
Active Surveillance of Candidemia, Australia
Chen, S., Slavin, M. A., Nguyen, Q. A., Marriott, D. J. E., Playford, E. G., Ellis, D., Sorrell, T. C., & Study, T. A. C. (2006) · Emerging infectious diseases · doi:10.3201/eid1210.060389 · Cited by 174 · see citing works
Guery, B. P., Arendrup, M. C., Auzinger, G., Azoulay, É., Borges Sá, M., Johnson, E. M., Müller, E., Putensen, C., Rotstein, C., Sganga, G., et al. (2009) · Intensive Care Medicine · doi:10.1007/s00134-008-1338-7 · Cited by 173 · see citing works
The Changing Face of Fungal Infections in Health Care Settings
Weinstein, R. A., & Fridkin, S. K. (2005) · Clinical Infectious Diseases · doi:10.1086/497138 · Cited by 170 · see citing works
Colombo, A. L., Guimarães, T., Silva, L. R. B. F., de Almeida, L. P., Cunha, A. K. B., Rady, P., Alves, T., & Rosas, R. C. (2007) · Infection Control and Hospital Epidemiology · doi:10.1086/513615 · Cited by 161 · see citing works
Mailles, A., Blanckaert, K., Chaud, P., van der Werf, S., Lina, B., Caro, V., Campese, C., Guery, B. P., Prouvost, H., Lemaire, X., et al. (2013) · Eurosurveillance · doi:10.2807/ese.18.24.20502-en · Cited by 152 · see citing works
Predictors and Outcomes of Candiduria in Renal Transplant Recipients
Safdar, N., Slattery, W. R., Knasinski, V., Gangnon, R. E., Li, Z., Pirsch, J. D., & Andes, D. R. (2005) · Clinical Infectious Diseases · doi:10.1086/429620 · Cited by 151 · see citing works
Spieß, B., Seifarth, W., Hummel, M., Frank, O., Fabarius, A. C., Zheng, C., Mörz, H., Hehlmann, R., & Buchheidt, D. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00942-07 · Cited by 149 · see citing works
Genome-Wide Transcription Profiling of the Early Phase of Biofilm Formation by Candida albicans
Murillo, L. A., Newport, G., Lan, C., Habelitz, S., Dungan, J. M., & Agabian, N. M. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.9.1562-1573.2005 · Cited by 149 · see citing works
Ortega, M., Marco, F., Soriano, À., Almela, M., Martínez, J. A., López, J. D. S., Pitart, C., & Mensa, J. (2011) · Journal of Hospital Infection · doi:10.1016/j.jhin.2010.09.026 · Cited by 145 · see citing works
Tortorano, A. M., Dho, G., Prigitano, A., Breda, G., Grancini, A., Emmi, V., Cavanna, C., Marino, G., Morero, S., Ossi, C. M., et al. (2011) · Mycoses · doi:10.1111/j.1439-0507.2011.02044.x · Cited by 142 · see citing works
Eggimann, P., & Pittet, D. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3355-z · Cited by 139 · see citing works
Self-citationEpidemiology of fungal infections in China
Chen, M., Xu, Y., Hong, N., Yang, Y., Lei, W., Du, L., Zhao, J., Lei, X., Xiong, L., Cai, L., et al. (2018) · Frontiers of Medicine · doi:10.1007/s11684-017-0601-0 · Cited by 137 · see citing works
Ruhnke, M., Rickerts, V., Cornely, O. A., Buchheidt, D., Glöckner, A., Heinz, W., Höhl, R., Horré, R., Karthaus, M., Kujath, P., et al. (2011) · Mycoses · doi:10.1111/j.1439-0507.2011.02040.x · Cited by 137 · see citing works
Systemic antifungal therapy in critically ill patients without invasive fungal infection*
Azoulay, É., Dupont, H., Tabah, A., Lortholary, O., Stahl, J. ‐., Français, A., Martin, C., Guidet, B., & Timsit, J. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e318236f297 · Cited by 136 · see citing works
A review of Candida species causing blood stream infection
Giri, S., & Kindo, A. J. (2012) · Indian Journal of Medical Microbiology · doi:10.4103/0255-0857.99484 · Cited by 132 · see citing works
Cuenca‐Estrella, M., Rodríguez-Pardo, D., Almirante, B., Morgan, J., Planes, A. M., Almela, M., Mensa, J., Sánchez, F., Ayats, J., Giménez, M., et al. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh548 · Cited by 132 · see citing works
Diagnosis of invasive candidiasis in the ICU
Eggimann, P., Billé, J., & Marchetti, O. (2011) · Annals of Intensive Care · doi:10.1186/2110-5820-1-37 · Cited by 131 · see citing works
Self-citationThe risk and clinical outcome of candidemia depending on underlying malignancy
The French Mycoses Study Group, Lortholary, O., Renaudat, C., Sitbon, K., Desnos‐Ollivier, M., Bretagne, S., & Dromer, F. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4743-y · Cited by 131 · see citing works
Invasive Candida species infections: a 5 year population-based assessment
Laupland, K. B., Gregson, D. B., Church, D. L., Ross, T., & Elsayed, S. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki258 · Cited by 129 · see citing works
Photodynamic inactivation for controlling Candida albicans infections
Gonzales, F. P., & Maisch, T. (2011) · Fungal Biology · doi:10.1016/j.funbio.2011.10.001 · Cited by 127 · see citing works
Global trends in candidemia: Review of reports from 1995–2005
Morgan, J. (2005) · Current Infectious Disease Reports · doi:10.1007/s11908-005-0044-7 · Cited by 127 · see citing works
Diagnosis and management of invasive candidiasis in the ICU: an updated approach to an old enemy
Calandra, T., Roberts, J. A., Antonelli, M. M., Bassetti, M., & Vincent, J. (2016) · Critical Care · doi:10.1186/s13054-016-1313-6 · Cited by 125 · see citing works
Self-citationOrasch, C., Marchetti, O., Garbino, J., Schrenzel, J., Zimmerli, S., Mühlethaler, K., Pfyffer, G. E., Ruef, C., Fehr, J. S., Zbinden, R., et al. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12440 · Cited by 122 · see citing works
Self-citationCruciani, M., de Lalla, F., & Mengoli, C. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2794-y · Cited by 122 · see citing works
Bassetti, M., Trecarichi, E. M., Righi, E., Sanguinetti, M., Bisio, F., Posteraro, B., Soro, O., Cauda, R., Viscoli, C., & Tumbarello, M. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.01.005 · Cited by 120 · see citing works
A 1-year prospective survey of candidemia in Italy and changing epidemiology over one decade
Tortorano, A. M., Prigitano, A., Lazzarini, C., Passera, M., Deiana, M. L., Cavinato, S., De Luca, C., Grancini, A., Lo Cascio, G., Ossi, C., et al. (2013) · Infection · doi:10.1007/s15010-013-0455-6 · Cited by 110 · see citing works
Zepelin, M. B., Kunz, L., Rüchel, R., Reichard, U., Weig, M., & Groß, U. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm145 · Cited by 109 · see citing works
Xiao, Z., Wang, Q., Zhu, F., & An, Y. (2019) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-019-0534-2 · Cited by 109 · see citing works
Oberoi, J. K., Wattal, C., Goel, N., Raveendran, R., Datta, S., & Prasad, K. (2012) · Europe PMC (PubMed Central) · Cited by 106 · see citing works
León, C., Ostrosky‐Zeichner, L., & Schuster, M. G. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3281-0 · Cited by 105 · see citing works
Epidemiology of invasive fungal infection
Castón, J. J., Rivero, A., & Torre‐Cisneros, J. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(08)70009-8 · Cited by 105 · see citing works
Clinical and Therapeutic Aspects of Candidemia: A Five Year Single Centre Study
Bassetti, M., Merelli, M., Ansaldi, F., de Florentiis, D., Sartor, A., Scarparo, C., Callegari, A., & Righi, E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127534 · Cited by 104 · see citing works
Angulo, F. J., & Scallan, E. (2007) · Clinical Infectious Diseases · doi:10.1086/511648 · Cited by 104 · see citing works
What has changed in the treatment of invasive candidiasis? A look at the past 10 years and ahead
Bassetti, M., Righi, E., Montravers, P., & Cornely, O. A. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx445 · Cited by 101 · see citing works
Chen, S. C. A., Marriott, D. J. E., Playford, E. G., Nguyen, Q. A., Ellis, D., Meyer, W., Sorrell, T. C., & Slavin, M. A. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02821.x · Cited by 99 · see citing works
UncommonCandidaSpecies Fungemia among Cancer Patients, Houston, Texas, USA
Jung, D. S., Farmakiotis, D., Jiang, Y., Tarrand, J. J., & Kontoyiannis, D. P. (2015) · Emerging infectious diseases · doi:10.3201/eid2111.150404 · Cited by 96 · see citing works
Twenty-two years of candidaemia surveillance: results from a Norwegian national study
Hesstvedt, L., Gaustad, P., Andersen, C. T., Haarr, E., Hannula, R., Haukland, H. H., Hermansen, N. O., Larssen, K. W., Mylvaganam, H., Ranheim, T. E., et al. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.06.008 · Cited by 94 · see citing works
Risk factors for candidaemia in critically ill patients: a prospective surveillance study*
Marcos, R. J., Álvarez-Lerma, F., Jurado, M., Palomar, M., Nolla‐Salas, J., de Leon, M. A. M., León, C., & the EPCAN Study Group (2007) · Mycoses · doi:10.1111/j.1439-0507.2007.01366.x · Cited by 94 · see citing works
Incidence of candidaemia and relationship with fluconazole use in an intensive care unit
Bassetti, M., Ansaldi, F., Nicolini, L. A., Malfatto, E. N., Molinari, M. P., Mussap, M., Rebesco, B., Pallavicini, F. B., Icardi, G., & Viscoli, C. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp251 · Cited by 93 · see citing works
Golan, Y., Wolf, M. P., Pauker, S. G., Wong, J. B., & Hadley, S. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-12-200512200-00004 · Cited by 93 · see citing works
Leroy, G., Lambiotte, F., Thévenin, D., Lemaire, C., Parmentier, E., Devos, P., & Leroy, O. (2011) · Annals of Intensive Care · doi:10.1186/2110-5820-1-50 · Cited by 92 · see citing works
Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007
Poikonen, E., Lyytikäinen, O., Anttila, V.-J., Koivula, I., Lumio, J., Kotilainen, P., Syrjälä, H., & Ruutu, P. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-312 · Cited by 92 · see citing works
Treatment options of invasive fungal infections in adults
Marchetti, O., Eggimann, P., Pittet, D., Glauser, M., & Calandra, T. (2006) · Swiss Medical Weekly · doi:10.4414/smw.2006.11392 · Cited by 89 · see citing works
Self-citationCandidemia in a Brazilian hospital: the importance of Candida parapsilosis
Medrano, D. J. A., Brilhante, R. S. N., Cordeiro, R. D. A., Rocha, M. F. G., Rabenhorst, S. H. B., & Sidrim, J. J. C. (2006) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s0036-46652006000100004 · Cited by 89 · see citing works
Gómez-Gaviria, M., & Mora-Montes, H. M. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s247944 · Cited by 88 · see citing works
Seyoum, E., Bitew, A., & Mihret, A. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-4883-5 · Cited by 87 · see citing works
Bhattacharjee, P. (2016) · Current Medical Mycology · doi:10.18869/acadpub.cmm.2.2.5 · Cited by 86 · see citing works
Antifungal stewardship in invasive Candida infections
Ruhnke, M. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12622 · Cited by 85 · see citing works
Invasive Candidiasis: An Overview from Taiwan
Ruan, S., & Hsueh, P. (2009) · Journal of the Formosan Medical Association · doi:10.1016/s0929-6646(09)60091-7 · Cited by 85 · see citing works
The effect of biomaterials and antifungals on biofilm formation by Candida species: a review
Cuéllar‐Cruz, M., Vega‐González, A., Mendoza‐Novelo, B., López-Romero, E., Ruiz‐Baca, E., Escorza, M. A. Q., & Villagómez-Castro, J. C. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-012-1634-6 · Cited by 82 · see citing works
Risk Factors for Fluconazole-Resistant Candida glabrata Bloodstream Infections
Lee, I., Fishman, N. O., Zaoutis, T. E., Morales, K. H., Weiner, M. G., Synnestvedt, M. B., Nachamkin, I., & Lautenbach, E. (2009) · Archives of Internal Medicine · doi:10.1001/archinte.169.4.379 · Cited by 82 · see citing works
da Matta, D. A., de Almeida, L. P., Machado, A. M. D. O., Azevedo, A. C., Kusano, E. J. U., Travassos, N. F., Salomão, R., & Colombo, A. L. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2006.10.011 · Cited by 82 · see citing works
Benedict, K., Roy, M., Kabbani, S., Anderson, E. J., Farley, M. M., Harb, S., Harrison, L. H., Bonner, L., Wadu, V. L., Marceaux, K., et al. (2018) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piy009 · Cited by 81 · see citing works
Candidaemia in internal medicine departments: the burden of a rising problem
Bassetti, M., Molinari, M. P., Mussap, M., Viscoli, C., & Righi, E. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12155 · Cited by 81 · see citing works
<i>Candida</i> Species: New Insights into Biofilm Formation
Cuéllar-Cruz, M., López-Romero, E., Villagómez-Castro, J. C., & Ruiz-Baca, E. (2012) · Future Microbiology · doi:10.2217/fmb.12.48 · Cited by 80 · see citing works
Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Barton, R., Bijie, H., Bille, J., Chang, S.-C., da Luz Martins, M., Duse, A., et al. (2010) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.01.002 · Cited by 80 · see citing works
- Authors
- Marchetti, O., Bille, J., Fluckiger, U., Eggimann, P., Ruef, C., Garbino, J., Calandra, T., Glauser, M., Tauber, M. G., Pittet, D., & Fungal Infection Network of Switzerland (FUNGINOS)
- Affiliations
- Centre Hospitalier Universitaire Vaudois (CH)
- University Hospital of Geneva (CH)
- University of Zurich (CH)
- Corresponding author
- Marchetti, Oscar
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-02
- Volume
- 38
- Issue
- 3
- Pages
- 311-320
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2156803121
- Semantic Scholar
- 0d5bcae50ab2bf491c4b0a502cd9e553f5257a3a
- Cited by
- 478
- References
- 34
- Citations by year
- 2026: 1 · 2025: 12 · 2024: 11 · 2023: 7 · 2022: 14 · 2021: 13 · 2020: 18 · 2019: 12 · 2018: 21 · 2017: 21 · 2016: 24 · 2015: 22 · 2014: 31 · 2013: 29 · 2012: 18
- FWCI
- 20.53
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- SERVAL (Université de Lausanne) (publishedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- reroDoc Digital Library (submittedVersion)
- IRIS (submittedVersion)
- BORIS (University Library Bern) (submittedVersion, other-oa)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Open Access CRIS of the University of Bern
- Funders
- Pfizer
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Yeasts and Rust Fungi Studies
- Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
- Keywords
- candidemia, Candida species, bloodstream infection, Candida albicans, Candida glabrata, Candida tropicalis, Candida parapsilosis, Candida krusei, azole resistance, transplant recipients, incidence trends, Switzerland
- MeSH terms
- Antifungal Agents, Candidiasis, Cross Infection, Data Collection, Drug Resistance, Microbial, Hospitals, University, Humans, Longitudinal Studies, Microbial Sensitivity Tests, Switzerland, United States, Fluconazole, Fungemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-05.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-05.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review